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Abstract
Objective: Neurological injury due to transient cerebral ischemia is a potential complication of cardiovascular surgery. The neuropro-
tective effect of magnesium, when given subcutaneously before the ischemia, was assessed in a rat model of transient global cerebral
ischemia.Methods: Thirty-six male Wistar albino rats were included to this randomized, controlled, prospective study. In 24 animals,
ischemia was induced with four-vessel occlusion technique with the duration of 15 min. MgSO4 was given 600 mg/kg subcutaneously 48 h
before the procedure in group 1 (n = 12). Similar volume of saline solution was used in animals of control group (group 2,n = 12). The
animals in group 3 (sham group,n = 12) were anesthetized and subjected to operative dissections without vascular occlusion. Physiological
parameters and somatosensory evoked-potentials (SEP) were monitored in animals before ischemia, during ischemia and in the first 30 min
of reperfusion. Their neurological outcome had been clinically evaluated and scored up to 4 days postischemia. The intergroup differences
were compared. Then the animals were sacrificed and their brains were processed for histopathological examination.Results: In group 3,
SEP amplitudes did not change during the procedures, and all animals recovered without neurologic deficits. At the end of ischemic period,
the average amplitude was reduced to 5± 3% of the baseline in all ischemic animals. This was followed by a gradual return to 87± 10%
and 83± 8% of the initial amplitude after 30 min of reperfusion in group 1 and group 2, respectively (P . 0.05). The average neurological
score was significantly higher in group 1 than in group 2 at 48, 72 and 96 h after the ischemic insult (P , 0.05). Histological observations
were clearly correlated with the neurological findings.Conclusion: The results suggest that subcutaneous MgSO4 reduces cerebral injury
and preserves neurologic function when given two days before the transient global ischemia in rats. 1998 Elsevier Science B.V. All rights
reserved
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1. Introduction
Permanent neurological injury due to transient cerebral
ischemia is a potential complication of cardiac surgery that
may occur during deliberate hypotension, with the tempor-
ary clamping of cerebral vessels or total circulatory arrest.
The reported prevalence of neurologic injury for these
operations ranges up to 25% [1,2]. A reliable pharmacolo-
gical regimen designed to reduce or eliminate ischemic
injury when given before the procedure could be of great
benefit in cardiovascular surgery.
In the pathogenesis of cerebral ischemic injury, release of
excessive amounts of excitatory amino acids (EAA) from
terminals of ischemic neurons into the extracellular space
European Journal of Cardio-thoracic Surgery 14 (1998) 82–88
1010-7940/98/$19.00  1998 Elsevier Science B.V. All rights reserved
PII S1010-7940(98)00140-7
* Corresponding author. Pamukkale U¨ niversitesi Hastanesi, Doktorlar
cad., PK 54, Denizli, Turkey. Tel.: +90 258 2410037; fax: +90 258
2661817.
1 The study was carried out in the Department of Cardiovascular Surgery
of the Medical Faculty of Pamukkale University, Denizli, Turkey.
D
ow
nloaded from
 https://academ
ic.oup.com
/ejcts/article/14/1/82/383619 by Pam
ukkale U
niversity user on 27 August 2020
are thought to be important [3,4]. Two possible mechanisms
for the induction of cell death by EAA have been suggested.
The first is the induction of Cl− and Na+ influx leading to
neuronal swelling, and the second is the induction of Ca2+
influx into neurons via theN-methyl-d-aspartate (NMDA)
receptor complex, resulting in delayed damage [3–5].
To date, a variety of pharmacological agents designed to
prevent NMDA receptor activation have been investigated
in an attempt to reduce the neural damage in those situa-
tions. Most of these have met with varying success and
some are presently being evaluated in several clinical trials
[6,7]. However, the use of these drugs have been limited
because of their neurotoxic and behavioral side effects [8].
MgSO4 is a readily available, inexpensive NMDA recep-
tor antagonist with a well-established profile in cardiovas-
cular practice. The cytoprotective effects of magnesium
ions have been shown in both in vivo and in vitro experi-
ments [9–12]. They play an important role in neural cellular
physiology by competing with calcium ions in the extracel-
lular space, acting as an endogenous calcium channel
blocker and gating NMDA receptor-associated ion channels
[13]. Additionally, they function as non-competitive antago-
nists of EAA receptors [10]. Magnesium may also be of
value in decreasing the metabolic rate and oxygen demand
of the postsynaptic cell because of its blocking effect on
neurotransmitter release at synaptic junctions [14]. On the
basis of these data, we investigated the effects of magne-
sium pre-treatment on histopathological changes and neu-
rological recovery in a rat model of transient global cerebral
ischemia.
2. Materials and methods
2.1. Animal preparation
After approval of the study by the local Institutional
Committee, experiments were performed on 36 male Wistar
albino rats weighing 235± 27 g (mean± SD). During the
surgical procedures, anesthesia was induced and then main-
tained with intraperitoneal ketamine 25 mg/kg fractionally
as needed. No animal received haemodynamic or ventila-
tory support. The animals placed in a nose cone to breath
oxygen at a rate of 0.5 l/min. Rectal temperature was mon-
itored and maintained close to 38°C under a warming light.
After the surgical procedures, the rats were returned to their
individual cages. Rat diet and water were freely available.
2.2. Experimental groups and surgical procedures
Rats were randomly allocated into three groups each con-
sisting of 12 rats. They were prepared for transient global
cerebral ischemia by using a four-vessel occlusion model.
On day 1, both vertebral arteries were electrocauterized at
the level of first cervical vertebra within alar foramina.
Then, another small longitudinal scalp incision was made
and two stainless steel screws placed on the skull over the
right parietal region in order to connect active and reference
electrodes and to record somatosensory evoked potentials
(SEP). The incisions were then closed and the rats were
allowed to awaken. In group 1, MgSO4 600 mg/kg was
given subcutaneously. A similar volume of saline solution
was given in control groups correspondingly.
Two days later, rats were reanesthetized. After the surgi-
cal preparation using aseptic techniques, a femoral artery
was exposed and catheterized. The catheter was connected
to a blood pressure/heart rate transducer and monitor (Hew-
lett-Packard 1495C). Determinations of blood glucose,
blood gases and pH were also accomplished with this line
(Stat Profile 5 autoanalyser). With a small midline ventral
neck incision, both carotid arteries were exposed and nylon
threads placed around them. In group 1 and group 2, ische-
mia was induced by pulling the nylon threads for 15 min.
Restoration of blood flow was verified visually. The incision
was closed after establishing the reperfusion. In group 3 of
animals (sham operated) neck incision was left open for 15
min corresponding to cerebral ischemia period but carotid
arteries were not occluded. This group of animals were used
for eliciting the effects of anesthesia and operation on
results.
2.3. SEP recording
In order to assess the recovery of cerebral electrical func-
tion, SEP were monitored before the occlusion of the carotid
arteries, during ischemia and first 30 min of reperfusion.
Nihon Kohden Neuropack II plus (MEB 5000) was used
for recordings. The active electrode was connected to the
screw located 2 mm lateral to the midline and over the
coronal suture. The reference electrode was connected to
the other screw located at the midline over the frontal
sinus (maxillary bone). A needle ground electrode was
placed on the left upper extremity. The left sciatic nerve
was stimulated by surface electrodes. The stimulus rate
was 3/s with a duration of 0.1 ms and the stimulus intensity
was 3–5 mA. Two-hundred and fifty-six responses were
averaged. Bandpass filter was set at 20 Hz to 1 kHz. SEP
responses were evaluated for recovery of the percentages of
their baseline control values obtained before carotid occlu-
sion.
2.4. Postoperative care and assessment
Femoral arterial line was removed at the 30th min of
reperfusion. When the animals awakened from anesthesia,
they were returned to their cages. Four animals (2 rats ori-
ginally assigned to the group 1 and others to group 2) died in
the early postoperative period (within the first 12 h) and they
were excluded from the study. Others survived without any
pathological finding except neurologic deficit. All animals
were weighed daily and had food and water intake moni-
tored.
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Neurological outcome was evaluated on each day using a
scoring system described by Capdeville et al. [15]. Briefly,
items rated were cranial nerve reflexes and sensory motor
functions. The total neurologic score for a normal rat was 24
(the sum of the scores of following items: corneal reflex, 2;
pinna reflex, 2; grasping reflex, 2; placing reaction, 6; right-
ing reflexes, 4; equilibrium tests, 4; flexion reflex, 2; spon-
taneous motility, 2). The neurological examinations of the
animals were performed by an independent neurologist who
was blinded to the study.
2.5. Histopathology
After the 4-day recovery period, rats were reanaesthe-
tized and killed with intracardiac perfusion of 10% neutral
formol. After decapitation, the heads were stored in the
same fixative overnight at 4°C. Afterwards, the brains
were removed and fixed in 10% buffered formalin solution
for 7 days. Right and left hippocampal regions were
obtained from coronal sections in frontal planes. Formaline
fixed, paraffin embedded sections (4mm thickness) were
stained with haematoxylin eosin and cresyl violet. The
CA1 and CA3 subfields of the hippocampus were examined
in both sides of the brain. Using an ocular micrometer
(Olympus ocular eye×10), all pyramidal neurons in four
different microscopic fields of both CA1 and CA3 regions
were counted. Ischemic damage were based on the percen-
tage of damaged neurons. Shrunken eosinophilic cytoplasm
and pyknotic nucleus were accepted as criteria for determi-
nation of ischemic neuronal damage. This procedure was
conducted in a blinded fashion.
2.6. Statistical analysis
Control variables such as blood pressures, blood gases
and pH were compared among groups with one way analy-
sis of variance. Non-parametric analysis with Wilcoxon-
Mann–Whitney U-test using the Bonferroni correction
were performed on the data of the neurological status
score. Comparison of the weight loss and recovery of SEP
amplitude values among the groups were made witht-test
and Bonferroni corrections. All data are expressed as the
mean± SD. A P value less than 0.05 was considered sig-
nificant.
3. Results
3.1. Physiological parameters
The vertebral electrocauterization induced a decrease in
body weight. The weight loss during the first 2 days did not
differ among the groups (group 1, 92± 2% of initial body
weight; group 2, 91± 3%; group 3, 92± 1%). At the end of
the 4-day recovery period, the animals in groups 1, 2, and 3
had 91± 2, 89 ± 3 and 92± 2% of their initial weights,
respectively. These differences among the groups were
not significant.
No differences in arterial blood gases, pH, blood glucose,
arterial pressures or body temperatures were noted among
the control groups and the group treated with magnesium
before the occlusion of carotid arteries. These physiological
parameters were in normal limits and stayed quite similar
during the procedure in all groups.
3.2. SEP recordings
SEP recordings consistently showed a small negative
peak (N1) with an average latency of 7.2± 0.6 ms and a
large positive peak (P1) with an average latency of 10.6 d±
1.1 ms. These were followed by a large negative peak with
some individual variations. The peaks were stable during
the procedure in group 3 (sham operated group). In ischemic
groups, All peaks progressively declined with an average of
4 ± 1.6 min after the occlusion of carotid arteries. At the
end of ischemic period, N1-P1 amplitude decreased to 0–
12% of preischemic baseline level in all animals. The aver-
age amplitude was reduced to 4± 3 and 5± 4% of the
baseline in groups 1 and 2, respectively (P . 0.05). This
was followed by a gradual return to 87± 10% of the initial
N1-P1 amplitude after 30 min of reperfusion in group 1.
This recovery was 83± 8% in group 2 animals
(P . 0.05). The typical changes in SEP amplitudes are
shown in Fig. 1.
3.3. Neurological status
Sham operated animals showed full neurological recov-
ery after the procedure. The evaluations of the neurologic
scores in groups 1 and 2 are presented in Table 1. All
ischemic animals exhibited neurologic deficiencies espe-
cially with loss of spontaneous motility and righting reflexes
Fig. 1. The typical changes in SEP recordings during the procedure. (A)
Preischemia. (B) At the end of ischemia. (C) At 30th minute of reperfu-
sion.
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after the procedure. This was followed by a gradual recov-
ery in most animals, but full neurologic recovery was not
seen in any of these animals. Neurological deficits persisted
in two animals in groups 1 and 4 animals in group 2 during
the 4-day recovery period. One animal in group 2 exhibited
additional deterioration in neurologic score within 24 to 48
h. The average neurologic score was significantly better in
magnesium pretreated animals than in group 2 postopera-
tively.
3.4. Histopathology
Pyramidal neurons in the CA1 and CA3 subfields of the
hippocampus were completely normal in appearance in
sham operated animals (Fig. 2). Surviving neurons was
markedly decreased specially in CA1 subfield in ischemic
animals (Figs. 3 and 4). In comparison with magnesium
pretreated animals, control group showed significantly
more damage in both CA1 and CA3 subfields. The percen-
tage of damaged neurons in CA1 was 36± 9% in group 1,
whereas group 2 had 47± 12% (P , 0.05). Similar but less
severe histopathological changes were seen in CA3 fields.
This field had 14± 10 and 23± 7% damaged neurons in
groups 1 and 2, respectively (P , 0.05). Pyramidal neurons
observed in CA3 were essentially unaffected in some ani-
mals in group 1. There was no additional remarkable focal
ischemic or hemorrhagic cerebral lesions in the examined
hippocampal regions in both groups 1 and 2.
4. Discussion
The data presented in the study demonstrate that signifi-
cant cerebral neuroprotection, measured as a reduction in
neuronal damage has been achieved with preischemic, sub-
cutaneous administration of MgSO4 in a rat model of tran-
sient global ischemia. Animals that were subjected to 15
min of global cerebral ischemia after receiving 600 mg/kg
MgSO4 exhibited better neurological outcomes. This con-
firms the previous reports demonstrating magnesium to be a
potent neuroprotective agent.
One possible mechanism for the beneficial effect of mag-
nesium is its positive role in general cellular metabolism and
function. Magnesium is essential for normal cell functions
such as membrane integrity, cellular respiration, transcrip-
tion by messenger RNA, protein synthesis, glucose and
energy metabolism, maintenance of normal Na+ and K+ gra-
dients, and regulation of Ca2+ transport and accumulation
[11,13,16]. A second neuroprotective mechanism probably
includes inhibition of EAA release, and/or blockade of the
NMDA-glutamate receptor. It is shown that by inhibiting
EAA with magnesium or specific glutamate antagonists,
anoxic neuronal death could be prevented in neuronal cell
culture [14]. The importance of inhibition of excitatory
synaptic transmission for preventing hypoxic neuronal
injury was further confirmed in hippocampal slice prepara-
tions. In this model, high concentrations of magnesium
reduced the vulnerability of neurons by blocking the
anoxia-induced depolarization and by enhancing postis-
chemic recovery of high-energy phosphates [12]. Another
mechanism by which magnesium may decrease the size of
brain infarct is cerebral vasodilatation. Extracellular mag-
nesium affects vascular smooth-muscle contraction by its
action on membrane permeability to calcium ions and
blocks calcium channels [17]. It has been shown that mag-
nesium improves blood flow to ischemic cortex and attenu-
ates infarct size in focal cerebral ischemia in rats [9].
In most previous studies, the protective effect of magne-
sium was evaluated in traumatic brain injury or focal ische-
mia models [9–11]. Thus, they are not as applicable as the
present study to the clinical setting of cardiac surgery and
total circulatory arrest leading to global cerebral ischemia.
In those studies, magnesium was administered just before or
after the ischemic insult. In this study, MgSO4 was adminis-
tered subcutaneously 2 days before the procedure to avoid
its acute side effects such as hypotension and hyperglisemia.
Intravenous administration of magnesium to humans
decreases total peripheral resistance by 20 to 30% [18]. It
Table 1
The neurologic scores of ischemic animals in group 1 (n = 10) and group 2
(n = 10) at postoperative 24th, 48th, 72nd and 96th hour
24th hour 28th hour 72nd hour 96th hour
Corneal reflex
Group 1 1.9± 0.3 1.9± 0.3 1.9± 0.3 1.9± 0.3
Group 2 1.6± 0.5 1.7± 0.5 1.7± 0.5 1.7± 0.5
Pinna reflex
Group 1 1.7± 0.5 1.8± 0.4 1.8± 0.4 1.8± 0.4
Group 2 1.5± 0.5 1.7± 0.5 1.7± 0.5 1.7± 0.5
Grasping reflex
Group 1 1.3± 0.5 1.5± 0.5 1.8± 0.4 1.8± 0.4
Group 2 1.2± 0.4 1.6± 0.5 1.6± 0.5 1.6± 0.5
Placing reac-
tion
Group 1 4.6± 1.1 4.8± 0.9 5.5± 0.7* 5.5 ± 0.7*
Group 2 4.1± 1.0 4.2± 1.1 4.3± 1.2 4.3± 1.2
Righting
reflexes
Group 1 2.2± 0.6 2.9± 0.7 3.4± 1.0 3.4± 1.1
Group 2 2.0± 0.5 2.5± 1.0 2.7± 0.8 2.8± 0.8
Equilibrium
test
Group 1 3.1± 0.7 3.2± 0.6 3.5± 0.7 3.5± 0.7
Group 2 2.9± 0.9 2.8± 0.9 3.1± 0.9 3.1± 0.9
Flexion reflex
Group 1 1.6± 0.5 1.6± 0.5 1.8± 0.4 1.8± 0.4
Group 2 1.4± 0.5 1.4± 0.5 1.6± 0.5 1.6± 0.5
Spontaneous
motility
Group 1 0.8± 0.6 1.4± 0.5 1.7± 0.5 1.7± 0.5
Group 2 0.7± 0.7 1.2± 0.8 1.5± 0.7 1.5± 0.7
Total average
scores
Group 1 17.2± 2.2 19.1± 1.9 21.4± 2.1* 21.4± 2.1*
Group 2 15.4± 2.1 17.1± 3.6 18.2± 3.8 18.3± 3.8
*Significantly different from group 2 (P , 0.05).
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is also known that hypermagnesemia may cause a reduction
in plasma insulin levels, resulting in hyperglicemia [10].
Hyperglycemia is known to aggravate the cerebral injury
that follows transient ischemia [19], and it might limit the
effectiveness of magnesium treatment for cerebral ischemia
[8]. Feldman et al. [11] has shown that 600 mg/kg subcuta-
neous MgSO4 did not lead significant changes in serum
osmolality and provided significant increase of Mg2+ con-
centration in brain tissue 48 h after the administration [11].
In the present study, we observed no significant difference
in blood pressure and blood glucose level among all com-
parable groups. We think this model is relevant to the clin-
ical situation that may be applied when one wishes to
increase tolerance of brain to ischemia before elective sur-
gery.
The rat four-vessel occlusion technique is a reliable
Fig. 2. Normal morphological appearance of unaltered structure of CA1 subfield of hippocampus (group 3, last neurologic score: 24;×40 hemotoxylin and
eosin).
Fig. 3. Severe ischemic damage in CA1 subfield of hippocampus. There are ischemic changes characterized by eosinophilic cytoplasm and pyknotic nuclei in
most pyramidal neurons (group 2, last neurologic score: 15, percentage of damaged neurons in CA1: 62%,×400 hemotoxylin and eosin).
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model for observation of the protective effects of investi-
gated agents on ischemia and reperfusion injury. However,
blood flow may remains in some animals because of indi-
vidual variations in the residual collateral circulation or
probable surgical insufficiency while cauterizing the verteb-
ral arteries. Monitoring of SEP or electroencephalographic
activity has been used in some previous studies for ensuring
duration and effectiveness of the global ischemia and exclu-
sion of the animals that did not display a significant changes
[20]. Previous studies have shown that the SEP reliably and
directly reflect the cerebral electrical function [20,21]. Thus,
we preferred SEP monitoring because of it is safe, easy and
it does not prolong the operative procedure. In the present
study, SEP amplitudes decreased to under 10% of their
preischemic values in most animals and there were no dif-
ferences in this decrement between groups 1 and 2. Mon-
itoring of SEP in this model has permitted observation of
similar collateral blood flow properties in studied groups of
animals. In the present study, although the difference in
recovery of SEP amplitudes did not attain statistical signifi-
cance, we observed significantly better neurologic outcomes
(P , 0.05) in MgSO4 treated group. This data demonstrates
that the SEP recovery during early reperfusion can not be
used as a reliable predictor of neurological outcome. The
similar lack of correlation of SEP recovery and postopera-
tive neurologic deficits has been reported in some articles
[22].
We used a scoring system described by Capdeville to
quantitate the neurological outcome. Although there are
some articles reporting lack of correlation of this neurologic
score with histological damage [23], our histological obser-
vations were clearly correlated with the neurological find-
ings. The pattern of neuronal vulnerability, with the greatest
cell lost in the CA1 was similar to that seen in other previous
experimental studies and confirms the particular sensitivity
of CA1 to ischemia [23,24]. It has been assumed that it is
due to a failure of recovery processes following excitatory
damage to this particular neural circuitry [25].
In conclusion, the results suggest that subcutaneous
MgSO4 treatment 2 days before the ischemic insult reduces
ischemic and reperfusion damage in transient cerebral glo-
bal ischemia and provide better neurologic outcome. How-
ever, an animal study such as this may not be fully
reproducible in humans. Further studies are needed to
define biochemical aspects of the neuroprotective mechan-
ism and to determine the correct dose necessary for max-
imal benefit.
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